Location & dates EMBL Heidelberg, Germany 8 - 10 Dec 2019 Register Now
Deadlines Registration - 27 Oct 2019 Abstract - 15 Sep 2019
organiser_WGC

Programme

Got something to say? Tweet it! #EWGtarget

Day 1 - Sunday 8 December 2019
TimeSpeaker
14:00 - 15:00 Registration
15:00 - 15:15 Opening remarks
15:15 - 16:00

Keynote speaker 1
Mark Daly - Institute for Molecular Medicine Finland FIMM, Finland

16:00 - 19:00 Session 1 - Genetics
16:00 - 16:30 Gosia Trynka - Wellcome Sanger Institute, UK
16:30 - 16:45 Selected talk
16:45 - 17:00

Selected talk

17:00 -17:30 Big data meets drug discovery
Astrid Ruefli-Brasse - 23andMe, USA
17:30 - 18:00

Coffee break

18:00 - 18:30

Guiding targets to success: Experiences progressing genetically validated targets through discovery and development
Janna Hutz - Eisai Andover innovative Medicines (AiM) Institute, USA

18:30 - 18:45

Selected talk

18:45 - 19:00

Selected talk

19:00 - 20:00

Dinner

20:00 - 22:00

Poster Session

Day 2 - Monday 9 December 2019
TimeSpeaker
09:00 - 12:00 Session 2 - Case studies
09:00 - 09:30 Calliope Dendrou - Wellcome Trust Centre for Human Genetics, UK
09:30 - 09:45 Selected talk
09:45 - 10:00

Selected talk

10:00 - 10:30

Validation of TREM2 as a therapeutic target in Alzheimer’s disease
Damien Crowther - AstraZeneca, UK

10:30 - 11:00

Coffee break

11:00 - 11:15 Selected talk
11:15 - 11:30 Selected talk
11:30 - 12:00 From SNPs to biology in autoimmune disease                      
James Lee - University of Cambridge, UK
12:00 - 13:30

Meet the speaker and lunch

13:30 - 16:30 Session 3 - Genome editing for target validation
13:30 - 14:00 Advanced CRISPR applications in primary human T cells
Eric Shifrut - University of California, San Francisco, USA
14:00 - 14:15 Selected talk
14:15 - 14:30 Selected talk
14:30 -15:00

Sandra Engle - Biogen, USA

15:00 -15:30

Coffee break

15:30 -16:00 New tools for high-throughput functional characterization of the human noncoding genome
Molly Gasperini- University of Washington, USA
16:00 - 16:15 Selected talk
16:15 -16:30 Selected talk
16:30 - 18:30 Poster session with beer and snacks
18:45 Buses depart to Christmas market and hotels
Day 3 - Tuesday 10 December 2019
TimeSpeaker
09:00 - 12:00 Session 4 - Relevant models for target validation
09:00 - 09:30 Understanding mechanisms of resistance: novel targets for cancer treatment
Dirk Jäger - National Center for Tumor Diseases, Germany
09:30 - 09:45 Selected talk
09:45 - 10:00 Selected talk
10:00 - 10:30

Organoids, a Patient in the Lab
Rob Vries - Hubrecht Organoid Technology, The Netherlands

10:30 - 11:00 Coffee break
11:00 - 11:15 Selected talk
11:15 - 11:30 Selected talk
11:30 - 12:00

Paolo Casale - insitro, USA

12:00 - 13:30

Meet the speaker and lunch

13:30 - 17:00 Session 5 - Computational methods and analysis
13:30 - 14:00 Using genomics to evaluate T-cell therapeutic targets
Hans Bitter - Bluebird bio, USA
14:00 - 14:15 Selected talk
14:15 - 14:30 Selected talk
14:30 - 15:00 Chris Spencer - Genomics plc, UK
15:00 - 15:30 Coffee break
15:30 - 15:45 Selected talk
15:45 - 16:15 Alexis Battle - Johns Hopkins University, USA
16:15 - 17:00 Keynote speaker 2
Edith Hessel - GSK, UK
17:00 - 17:15 Closing remarks and poster prize
17:30 Buses depart to downtown and airport